Literature DB >> 14573629

One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Kabilan Velliyagounder1, Jeffrey B Kaplan, David Furgang, Diana Legarda, Gill Diamond, Ruth E Parkin, Daniel H Fine.   

Abstract

The iron-binding protein lactoferrin is a ubiquitous and abundant constituent of human exocrine secretions. Lactoferrin inhibits bacterial growth by sequestering essential iron and also exhibits non-iron-dependent antibacterial, antifungal, antiviral, antitumor, anti-inflammatory, and immunoregulatory activities. All of these non-iron-dependent activities are mediated by the highly charged N terminus of lactoferrin. In this study we characterized a Lys/Arg polymorphism at position 29 in the N-terminal region of human lactoferrin that results from a single nucleotide polymorphism in exon 1 of the human lactoferrin gene. We expressed cDNAs encoding both lactoferrin variants in insect cells and purified the two proteins by ion exchange chromatography. The two lactoferrin variants exhibited nearly identical iron-binding and iron-releasing activities and equivalent bactericidal activities against a strain of the gram-negative bacterium Actinobacillus actinomycetemcomitans. When tested against the gram-positive species Streptococcus mutans and Streptococcus mitis, however, lactoferrin containing Lys at position 29 exhibited significantly greater bactericidal activity than did lactoferrin containing Arg. In addition, the Lys-containing lactoferrin stimulated bovine tracheal epithelial cells to synthesize much higher levels of tracheal antimicrobial peptide mRNA than did the Arg-containing variant. A genotyping assay that distinguished between the two alleles based on a polymorphic EarI restriction site showed that the Lys and Arg alleles had frequencies of 24% and 76%, respectively, among 17 healthy human subjects, and 72% and 28%, respectively, among nine patients with localized juvenile periodontitis. Our findings suggest that these two lactoferrin variants are functionally different and that these differences may contribute to the pathogenesis of localized juvenile periodontitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573629      PMCID: PMC219577          DOI: 10.1128/IAI.71.11.6141-6147.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

Review 1.  Lactoferrin: a multifunctional glycoprotein.

Authors:  L H Vorland
Journal:  APMIS       Date:  1999-11       Impact factor: 3.205

Review 2.  Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process.

Authors:  S Baveye; E Elass; J Mazurier; G Spik; D Legrand
Journal:  Clin Chem Lab Med       Date:  1999-03       Impact factor: 3.694

3.  Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells.

Authors:  G Diamond; J P Russell; C L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

4.  Characterization of human lactoferrin produced in the baculovirus expression system.

Authors:  V Salmon; D Legrand; B Georges; M C Slomianny; B Coddeville; G Spik
Journal:  Protein Expr Purif       Date:  1997-03       Impact factor: 1.650

5.  Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.

Authors:  D S Chapple; D J Mason; C L Joannou; E W Odell; V Gant; R W Evans
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis.

Authors:  J Groenink; E Walgreen-Weterings; K Nazmi; J G Bolscher; E C Veerman; A J van Winkelhoff; A V Nieuw Amerongen
Journal:  J Clin Periodontol       Date:  1999-05       Impact factor: 8.728

7.  Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects.

Authors:  F R Sallmann; S Baveye-Descamps; F Pattus; V Salmon; N Branza; G Spik; D Legrand
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

8.  Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

Authors:  D Yang; O Chertov; S N Bykovskaia; Q Chen; M J Buffo; J Shogan; M Anderson; J M Schröder; J M Wang; O M Howard; J J Oppenheim
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

9.  Phenotypic variation in Actinobacillus actinomycetemcomitans during laboratory growth: implications for virulence.

Authors:  D H Fine; D Furgang; H C Schreiner; P Goncharoff; J Charlesworth; G Ghazwan; P Fitzgerald-Bocarsly; D H Figurski
Journal:  Microbiology       Date:  1999-06       Impact factor: 2.777

10.  Lactoferrin iron levels are reduced in saliva of patients with localized aggressive periodontitis.

Authors:  D H Fine; D Furgang; F Beydouin
Journal:  J Periodontol       Date:  2002-06       Impact factor: 6.993

View more
  24 in total

1.  Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.

Authors:  Yanhong Zhou; Wei Wang; Danwei Zheng; Shuping Peng; Wei Xiong; Jian Ma; Zhaoyang Zeng; Minghua Wu; Ming Zhou; Juanjuan Xiang; Bo Xiang; Xiaoling Li; Xiayu Li; Guiyuan Li
Journal:  Med Oncol       Date:  2011-10-20       Impact factor: 3.064

2.  Analysis of new lactotransferrin gene variants in a case-control study related to periodontal disease in dog.

Authors:  Francisco Morinha; Carlos Albuquerque; João Requicha; Isabel Dias; José Leitão; Ivo Gut; Henrique Guedes-Pinto; Carlos Viegas; Estela Bastos
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

3.  Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice.

Authors:  Senthil Kumar Velusamy; Daniel H Fine; Kabilan Velliyagounder
Journal:  Microbes Infect       Date:  2014-08-11       Impact factor: 2.700

Review 4.  Lactoferrin: A Roadmap to the Borderland between Caries and Periodontal Disease.

Authors:  D H Fine
Journal:  J Dent Res       Date:  2015-03-17       Impact factor: 6.116

Review 5.  Low levels of caries in aggressive periodontitis: A literature review.

Authors:  Srinivas Sulugodu Ramachandra
Journal:  Saudi Dent J       Date:  2013-12-14

6.  In vitro efficacy of diallyl sulfides against the periodontopathogen Aggregatibacter actinomycetemcomitans.

Authors:  Kabilan Velliyagounder; Krishnaraj Ganeshnarayan; Senthil Kumar Velusamy; Daniel H Fine
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

7.  Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.

Authors:  Gengqiu Luo; Yanhong Zhou; Wei Yi; Hong Yi
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

8.  Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens.

Authors:  Nicholas Beckloff; Danielle Laube; Tammy Castro; David Furgang; Steven Park; David Perlin; Dylan Clements; Haizhong Tang; Richard W Scott; Gregory N Tew; Gill Diamond
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

9.  Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin.

Authors:  Hiroyuki Wakabayashi; Natsuko Takakura; Koji Yamauchi; Yoshitaka Tamura
Journal:  Clin Vaccine Immunol       Date:  2006-02

10.  Role of salivary and candidal proteins in denture stomatitis: an exploratory proteomic analysis.

Authors:  Warren C Byrd; Sarah Schwartz-Baxter; Jim Carlson; Silvana Barros; Steven Offenbacher; Sompop Bencharit
Journal:  Mol Biosyst       Date:  2014-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.